For: | Qi J, Zhu YQ, Luo J, Tao WH. Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor. World J Gastroenterol 2006; 12(44): 7113-7117 [PMID: 17131472 DOI: 10.3748/wjg.v12.i44.7113] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i44/7113.htm |
Number | Citing Articles |
1 |
Shoaib Shoaib, Mohammad Azam Ansari, Mohammed Ghazwani, Umme Hani, Yahya F. Jamous, Zahraa Alali, Shadma Wahab, Wasim Ahmad, Sydney A. Weir, Mohammad N. Alomary, Nabiha Yusuf, Najmul Islam. Prospective Epigenetic Actions of Organo-Sulfur Compounds against Cancer: Perspectives and Molecular Mechanisms. Cancers 2023; 15(3): 697 doi: 10.3390/cancers15030697
|
2 |
Kiyoshi Mori, Riko Kitazawa, Takeshi Kondo, Michiko Mori, Yasuhiro Hamada, Michiru Nishida, Yasuhiro Minami, Ryuma Haraguchi, Yutaka Takahashi, Sohei Kitazawa, Yanqiao Zhang. Diabetic Osteopenia by Decreased β-Catenin Signaling Is Partly Induced by Epigenetic Derepression of sFRP-4 Gene. PLoS ONE 2014; 9(7): e102797 doi: 10.1371/journal.pone.0102797
|
3 |
Shijie Mo, Zexuan Su, Baoli Heng, Weijun Chen, Liping Shi, Xinghua Du, Caiyong Lai. SFRP1 Promoter Methylation and Renal Carcinoma Risk: A Systematic Review and Meta-Analysis. Journal of Nippon Medical School 2018; 85(2): 78 doi: 10.1272/jnms.2018_85-13
|
4 |
Dao-Rong Wang, Dong Tang. Hypermethylated <italic>SFRP2</italic> gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening. World Journal of Gastroenterology 2008; 14(4): 524-531 doi: 10.3748/wjg.14.524
|
5 |
Quirinus JM Voorham, Jerry Janssen, Marianne Tijssen, Suzanne Snellenberg, Sandra Mongera, Nicole CT van Grieken, Heike Grabsch, Martin Kliment, Bjorn J Rembacken, Chris JJ Mulder, Manon van Engeland, Gerrit A Meijer, Renske DM Steenbergen, Beatriz Carvalho. Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas. BMC Cancer 2013; 13(1) doi: 10.1186/1471-2407-13-603
|
6 |
Michael Oberwalder, Marion Zitt, Cornelia Wöntner, Heidi Fiegl, Georg Goebel, Matthias Zitt, Olivia Köhle, Gilbert Mühlmann, Dietmar Öfner, Raimund Margreiter, Hannes M. Müller. SFRP2 methylation in fecal DNA—a marker for colorectal polyps. International Journal of Colorectal Disease 2007; 23(1): 15 doi: 10.1007/s00384-007-0355-2
|
7 |
Parisa Aghagolzadeh, Ramin Radpour. New trends in molecular and cellular biomarker discovery for colorectal cancer. World Journal of Gastroenterology 2016; 22(25): 5678-5693 doi: 10.3748/wjg.v22.i25.5678
|
8 |
Rohit Surana, Sakshi Sikka, Wanpei Cai, Eun Myoung Shin, Sudha R. Warrier, Hong Jie Gabriel Tan, Frank Arfuso, Simon A. Fox, Arun M. Dharmarajan, Alan Prem Kumar. Secreted frizzled related proteins: Implications in cancers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2014; 1845(1): 53 doi: 10.1016/j.bbcan.2013.11.004
|
9 |
Sharad Khare, Kamran Chaudhary, Marc Bissonnette, Robert Carroll. Cancer Epidemiology. Methods in Molecular Biology 2009; 472: 373 doi: 10.1007/978-1-60327-492-0_17
|
10 |
Hu Zhang, Jian Qi, Ya-Qiong Wu, Ping Zhang, Jun Jiang, Qi-Xian Wang, You-Qing Zhu. Accuracy of early detection of colorectal tumours by stool methylation markers: A meta-analysis. World Journal of Gastroenterology 2014; 20(38): 14040-14050 doi: 10.3748/wjg.v20.i38.14040
|
11 |
Jongbum Kim, Sangsoo Kim. In silicoIdentification ofSFRP1as a Hypermethylated Gene in Colorectal Cancers. Genomics & Informatics 2014; 12(4): 171 doi: 10.5808/GI.2014.12.4.171
|
12 |
Barbara Kinga Barták, Alexandra Kalmár, Bálint Péterfia, Árpád V. Patai, Orsolya Galamb, Gábor Valcz, Sándor Spisák, Barnabás Wichmann, Zsófia Brigitta Nagy, Kinga Tóth, Zsolt Tulassay, Péter Igaz, Béla Molnár. Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 in plasma samples. Epigenetics 2017; 12(9): 751 doi: 10.1080/15592294.2017.1356957
|
13 |
Anja Kafka, Nives Pećina-Šlaus, Denis Drmić, Anja Bukovac, Niko Njirić, Kamelija Žarković, Antonia Jakovčević. SFRP4 protein expression is reduced in high grade astrocytomas which is not caused by the methylation of its promoter. Frontiers in Molecular Neuroscience 2024; 17 doi: 10.3389/fnmol.2024.1398872
|
14 |
TEOW KOK-SIN, NORFILZA MOHD MOKHTAR, NUR ZARINA ALI HASSAN, ISMAIL SAGAP, ISA MOHAMED ROSE, ROSLAN HARUN, RAHMAN JAMAL. Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data. Oncology Reports 2015; 34(1): 22 doi: 10.3892/or.2015.3993
|
15 |
YOUTU WU, JIWEI BAI, LINCHUAN HONG, CHUNHUI LIU, SHENGYUAN YU, GUOQIANG YU, YAZHUO ZHANG. Low expression of secreted frizzled-related protein 2 and nuclear accumulation of β-catenin in aggressive nonfunctioning pituitary adenoma. Oncology Letters 2016; 12(1): 199 doi: 10.3892/ol.2016.4560
|
16 |
Teresita Muñoz-Antonia, Mariclara Torrellas-Ruiz, Jonathan Clavell, Linda A. Mathews, Carlos A. Muro-Cacho, Adriana Báez. Aberrant Methylation Inactivates Transforming Growth FactorβReceptor I in Head and Neck Squamous Cell Carcinoma. International Journal of Otolaryngology 2009; 2009: 1 doi: 10.1155/2009/848695
|
17 |
Wei Zhang, Sabine C. Glöckner, Mingzhou Guo, Emi Ota Machida, David H. Wang, Hariharan Easwaran, Leander Van Neste, James G. Herman, Kornel E. Schuebel, D. Neil Watkins, Nita Ahuja, Stephen B. Baylin. Epigenetic Inactivation of the Canonical Wnt Antagonist SRY-Box Containing Gene 17 in Colorectal Cancer. Cancer Research 2008; 68(8): 2764 doi: 10.1158/0008-5472.CAN-07-6349
|
18 |
Victoria Valinluck Lao, William M. Grady. Epigenetics and colorectal cancer. Nature Reviews Gastroenterology & Hepatology 2011; 8(12): 686 doi: 10.1038/nrgastro.2011.173
|
19 |
Pushpinder Kaur, Samson Mani, Marie-Pierre Cros, Jean-Yves Scoazec, Isabelle Chemin, Pierre Hainaut, Zdenko Herceg. Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma. Tumor Biology 2012; 33(2): 325 doi: 10.1007/s13277-012-0331-5
|
20 |
YOUTU WU, CHUNHUI LIU, SHENGYUAN YU, HUA GAO, ZHENYE LI, CHUZHONG LI, YAZHUO ZHANG. Assessment of sFRP4 as a bio-marker for predicting aggressiveness and recurrence of growth hormone-secreting pituitary adenomas. Oncology Reports 2016; 35(5): 2991 doi: 10.3892/or.2016.4650
|
21 |
Jingxin Ye, Jianfeng Zhang, Weifeng Ding. DNA methylation modulates epigenetic regulation in colorectal cancer diagnosis, prognosis and precision medicine. Exploration of Targeted Anti-tumor Therapy 2024; 5(1): 34 doi: 10.37349/etat.2024.00203
|
22 |
Carsten Stuckenholz, Lili Lu, Prakash C. Thakur, Tae-Young Choi, Donghun Shin, Nathan Bahary, Sheng-Ping Lucinda Hwang. Sfrp5 Modulates Both Wnt and BMP Signaling and Regulates Gastrointestinal Organogensis in the Zebrafish, Danio rerio. PLoS ONE 2013; 8(4): e62470 doi: 10.1371/journal.pone.0062470
|
23 |
Sylvain Lecomte, Florence Demay, François Ferrière, Farzad Pakdel. Phytochemicals Targeting Estrogen Receptors: Beneficial Rather Than Adverse Effects?. International Journal of Molecular Sciences 2017; 18(7): 1381 doi: 10.3390/ijms18071381
|
24 |
Xiao-yan Zhang, Lin Wang, Yuhuan Qiao, Ruixia Guo. Expressions of sFRP1 and β-Catenin in Cervical Cancer. Journal of Medical Biochemistry 2012; 31(1): 6 doi: 10.2478/v10011-011-0040-4
|
25 |
Tyler McInnes, Donghui Zou, Dasari S. Rao, Francesca M. Munro, Vicky L. Phillips, John L. McCall, Michael A. Black, Anthony E. Reeve, Parry J. Guilford. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3226-4
|
26 |
Brian Ko, Marina Hanna, Ming Yu, William M. Grady. Cancer Epigenetics. Epigenetics and Human Health 2023; 11: 331 doi: 10.1007/978-3-031-42365-9_10
|
27 |
Mohammad Fahad Ullah, Shazia Usmani, Aaliya Shah, Faisel M. Abuduhier. Dietary molecules and experimental evidence of epigenetic influence in cancer chemoprevention: An insight. Seminars in Cancer Biology 2022; 83: 319 doi: 10.1016/j.semcancer.2020.10.011
|
28 |
Uttara Saran, Frank Arfuso, Nikolajs Zeps, Arunasalam Dharmarajan. Secreted frizzled-related protein 4 expression is positively associated with responsiveness to Cisplatin of ovarian cancer cell lines in vitro and with lower tumour grade in mucinous ovarian cancers. BMC Cell Biology 2012; 13(1) doi: 10.1186/1471-2121-13-25
|
29 |
Heba F. Pasha, Mohamed I. Radwan, Ahmed M. Yehia, Mostafa M. Toam. Circulating methylated RUNX3 and SFRP1 genes as a noninvasive panel for early detection of colorectal cancer. European Journal of Gastroenterology & Hepatology 2019; 31(11): 1342 doi: 10.1097/MEG.0000000000001532
|
30 |
Jürgen Veeck, Erik Noetzel, Nuran Bektas, Edgar Jost, Arndt Hartmann, Ruth Knüchel, Edgar Dahl. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer. Molecular Cancer 2008; 7(1) doi: 10.1186/1476-4598-7-83
|
31 |
Ryuma Haraguchi, Riko Kitazawa, Kiyoshi Mori, Ryosuke Tachibana, Hiroshi Kiyonari, Yuuki Imai, Takaya Abe, Sohei Kitazawa. sFRP4-dependent Wnt signal modulation is critical for bone remodeling during postnatal development and age-related bone loss. Scientific Reports 2016; 6(1) doi: 10.1038/srep25198
|
32 |
Uttara Saran, Krishna Priya Mani, Uma Maheswari Balaguru, Akila Swaminathan, Shunmugam Nagarajan, Arun M. Dharmarajan, Suvro Chatterjee. sFRP4 signalling of apoptosis and angiostasis uses nitric oxide-cGMP-permeability axis of endothelium. Nitric Oxide 2017; 66: 30 doi: 10.1016/j.niox.2017.02.012
|
33 |
Tamotsu Sugai, Masakazu Yoshida, Makoto Eizuka, Noriyuki Uesugii, Wataru Habano, Kouki Otsuka, Akira Sasaki, Eiichiro Yamamoto, Takayuki Matsumoto, Hiromu Suzuki. Analysis of the DNA methylation level of cancer-related genes in colorectal cancer and the surrounding normal mucosa. Clinical Epigenetics 2017; 9(1) doi: 10.1186/s13148-017-0352-4
|
34 |
Chandra Kirana, Eric Smith, Doan T Ngo, Markus I Trochsler, Peter J Hewett, Richard S Stubbs, Jennifer E Hardingham, Guy J Maddern, Ehud Hauben. High Preoperative Levels of Circulating SFRP5 Predict Better Prognosis in Colorectal Cancer Patients. Future Oncology 2020; 16(31): 2499 doi: 10.2217/fon-2020-0356
|
35 |
Khatere Mokhtari, Maryam Peymani, Mohsen Rashidi, Kiavash Hushmandi, Kamran Ghaedi, Afshin Taheriazam, Mehrdad Hashemi. Colon cancer transcriptome. Progress in Biophysics and Molecular Biology 2023; : 49 doi: 10.1016/j.pbiomolbio.2023.04.002
|
36 |
Karyn L. Sheaffer, Ellen N. Elliott, Klaus H. Kaestner. DNA Hypomethylation Contributes to Genomic Instability and Intestinal Cancer Initiation. Cancer Prevention Research 2016; 9(7): 534 doi: 10.1158/1940-6207.CAPR-15-0349
|
37 |
Myoung Sook Kim, Joost Louwagie, Beatriz Carvalho, Jochim S. Terhaar sive Droste, Hannah Lui Park, Young Kwang Chae, Keishi Yamashita, Junwei Liu, Kimberly Laskie Ostrow, Shizhang Ling, Rafael Guerrero-Preston, Semra Demokan, Zubeyde Yalniz, Nejat Dalay, Gerrit A. Meijer, Wim Van Criekinge, David Sidransky, Jonathan Weitzman. Promoter DNA Methylation of Oncostatin M receptor-β as a Novel Diagnostic and Therapeutic Marker in Colon Cancer. PLoS ONE 2009; 4(8): e6555 doi: 10.1371/journal.pone.0006555
|
38 |
Soraya Bilvayeh, Zohreh Rahimi, Kheirollah Yari, Shayan Mostafaei. A systematic review and meta-analysis of the DNA methylation in colorectal cancer among Iranian population. Gene Reports 2021; 23: 101080 doi: 10.1016/j.genrep.2021.101080
|
39 |
Zhongchuan Wang, Rujia Li, Yongshan He, Shiyong Huang. Effects of secreted frizzled-related protein 1 on proliferation, migration, invasion, and apoptosis of colorectal cancer cells. Cancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0543-x
|
40 |
Andy J. Chien, William H. Conrad, Randall T. Moon. A Wnt Survival Guide: From Flies to Human Disease. Journal of Investigative Dermatology 2009; 129(7): 1614 doi: 10.1038/jid.2008.445
|
41 |
Gábor Valcz, Árpád V. Patai, Alexandra Kalmár, Bálint Péterfia, István Fűri, Barnabás Wichmann, Györgyi Műzes, Ferenc Sipos, Tibor Krenács, Emese Mihály, Sándor Spisák, Béla Molnár, Zsolt Tulassay, Edna Cukierman. Myofibroblast-Derived SFRP1 as Potential Inhibitor of Colorectal Carcinoma Field Effect. PLoS ONE 2014; 9(11): e106143 doi: 10.1371/journal.pone.0106143
|
42 |
R Salehi, M Mohammadi, MH Emami, AR Salehi. Methylation pattern of SFRP1 promoter in stool sample is a potential marker for early detection of colorectal cancer. Advanced Biomedical Research 2012; 1(1): 87 doi: 10.4103/2277-9175.105169
|
43 |
Chiara Bedin, Maria Vittoria Enzo, Paola Del Bianco, Salvatore Pucciarelli, Donato Nitti, Marco Agostini. Diagnostic and prognostic role of cell‐free DNA testing for colorectal cancer patients. International Journal of Cancer 2017; 140(8): 1888 doi: 10.1002/ijc.30565
|
44 |
Meredith Tennis, Michelle Van Scoyk, Robert A. Winn. Role of the Wnt Signaling Pathway and Lung Cancer. Journal of Thoracic Oncology 2007; 2(10): 889 doi: 10.1097/JTO.0b013e318153fdb1
|
45 |
Runhao Li, Saifei Liu, Kenny Yeo, Suzanne Edwards, Man Ying Li, Ryan Santos, Sima Kianpour Rad, Fangmeinuo Wu, Guy Maddern, Joanne Young, Yoko Tomita, Amanda Townsend, Kevin Fenix, Ehud Hauben, Timothy Price, Eric Smith. Diagnostic and prognostic significance of circulating secreted frizzled‐related protein 5 in colorectal cancer. Cancer Medicine 2024; 13(11) doi: 10.1002/cam4.7352
|
46 |
Veronika Buxhofer-Ausch, Christoph Ausch, Angelika Reiner, Kirsten Müllner-Ammer, Alfons Schmid, Stephan Kriwanek, Christian Sebesta, Gabriele Halwachs-Baumann, Gernot Kriegshäuser. SFRP1 promotor methylation analysis of FTA card touch-prep samples derived from colonic polyps. Experimental and Molecular Pathology 2020; 114: 104397 doi: 10.1016/j.yexmp.2020.104397
|
47 |
S Mahmoud A Najafi. The Canonical Wnt Signaling (Wnt/β-Catenin Pathway): A Potential Target for Cancer Prevention and Therapy. Iranian Biomedical Journal 2020; 24(5): 264 doi: 10.29252/ibj.24.5.264
|
48 |
Wenqiang Zhang, Kexin Zhang, Yanhui Ma, Yixin Song, Tongbing Qi, Guoji Xiong, Yuanzhu Zhang, Chengxia Kan, Jingwen Zhang, Fang Han, Xiaodong Sun. Secreted frizzled-related proteins: A promising therapeutic target for cancer therapy through Wnt signaling inhibition. Biomedicine & Pharmacotherapy 2023; 166: 115344 doi: 10.1016/j.biopha.2023.115344
|
49 |
Chih‐Ming Ho, Hung‐Cheng Lai, Shih‐Hung Huang, Tsai‐Yen Chien, Ming‐Chieh Lin, Shwu‐Fen Chang. Promoter methylation of sFRP5 in patients with ovarian clear cell adenocarcinoma. European Journal of Clinical Investigation 2010; 40(4): 310 doi: 10.1111/j.1365-2362.2010.02266.x
|
50 |
Omar Kabbarah, Cristina Nogueira, Bin Feng, Rosalynn M. Nazarian, Marcus Bosenberg, Min Wu, Kenneth L. Scott, Lawrence N. Kwong, Yonghong Xiao, Carlos Cordon-Cardo, Scott R. Granter, Sridhar Ramaswamy, Todd Golub, Lyn M. Duncan, Stephan N. Wagner, Cameron Brennan, Lynda Chin, Mikhail V. Blagosklonny. Integrative Genome Comparison of Primary and Metastatic Melanomas. PLoS ONE 2010; 5(5): e10770 doi: 10.1371/journal.pone.0010770
|
51 |
Yoshinaga Okugawa, William M. Grady, Ajay Goel. Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers. Gastroenterology 2015; 149(5): 1204 doi: 10.1053/j.gastro.2015.07.011
|
52 |
Li Song, Zhuo-Yu Li, Wei-Ping Liu, Mei-Rong Zhao. Crosstalk between Wnt/β-catenin and Hedgehog/Gli signaling pathways in colon cancer and implications for therapy. Cancer Biology & Therapy 2015; 16(1): 1 doi: 10.4161/15384047.2014.972215
|
53 |
Eun K. Choe, Jin W. Yi, Young J. Chai, Kyu J. Park. Upregulation of the adipokine genes ADIPOR1 and SPP1 is related to poor survival outcomes in colorectal cancer. Journal of Surgical Oncology 2018; 117(8): 1833 doi: 10.1002/jso.25078
|
54 |
Kristin Wallace, Maria V. Grau, A. Joan Levine, Lanlan Shen, Randala Hamdan, Xinli Chen, Jiang Gui, Robert W. Haile, Elizabeth L. Barry, Dennis Ahnen, Gail McKeown-Eyssen, John A. Baron, Jean Pierre J. Issa. Association between Folate Levels and CpG Island Hypermethylation in Normal Colorectal Mucosa. Cancer Prevention Research 2010; 3(12): 1552 doi: 10.1158/1940-6207.CAPR-10-0047
|
55 |
Michael T Buckley, Joanne Yoon, Herman Yee, Luis Chiriboga, Leonard Liebes, Gulshan Ara, Xiaozhong Qian, Dean F Bajorin, Tung-Tien Sun, Xue-Ru Wu, Iman Osman. The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo. Journal of Translational Medicine 2007; 5(1) doi: 10.1186/1479-5876-5-49
|
56 |
Stefan David, Stephen J. Meltzer. Pre-Invasive Disease: Pathogenesis and Clinical Management. 2011; : 41 doi: 10.1007/978-1-4419-6694-0_4
|
57 |
Sinem DURMUŞ, Berrin PAPİLA KUNDAKTEPE, Remise GELİŞGEN, Çiğdem PAPİLA, Hafize UZUN. EXPLORING THE ROLE OF sFRP-4, TFF-3, NF-кB AND ROMO1 LEVELS IN COLORECTAL CANCER: IMPLICATIONS FOR PATHOPHYSIOLOGY AND DISEASE PROGRESSION. Acta Medica Nicomedia 2024; 7(1): 120 doi: 10.53446/actamednicomedia.1391225
|
58 |
Iman Akhlaghipour, Amir Reza Bina, Mohammad Reza Abbaszadegan, Meysam Moghbeli. Methylation as a critical epigenetic process during tumor progressions among Iranian population: an overview. Genes and Environment 2021; 43(1) doi: 10.1186/s41021-021-00187-1
|
59 |
Jihong Fu, Wentao Tang, Peng Du, Guanghui Wang, Wei Chen, Jingming Li, Yunxiang Zhu, Jun Gao, Long Cui. Identifying MicroRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis. BMC Systems Biology 2012; 6(1) doi: 10.1186/1752-0509-6-68
|
60 |
Gemma Ferrer-Mayorga, Alberto Muñoz, José Manuel González-Sancho. Feldman and Pike's Vitamin D. 2024; : 859 doi: 10.1016/B978-0-323-91338-6.00039-2
|
61 |
James B. Rawson, Michael Manno, Miralem Mrkonjic, Darshana Daftary, Elizabeth Dicks, Daniel D. Buchanan, H. Banfield Younghusband, Patrick S. Parfrey, Joanne P. Young, Aaron Pollett, Roger C. Green, Steven Gallinger, John R. McLaughlin, Julia A. Knight, Bharati Bapat. Promoter methylation of Wnt antagonistsDKK1andSFRP1is associated with opposing tumor subtypes in two large populations of colorectal cancer patients. Carcinogenesis 2011; 32(5): 741 doi: 10.1093/carcin/bgr020
|
62 |
Micah G. Donovan, Ornella I. Selmin, Tom C. Doetschman, Donato F. Romagnolo. Mediterranean Diet: Prevention of Colorectal Cancer. Frontiers in Nutrition 2017; 4 doi: 10.3389/fnut.2017.00059
|
63 |
Dalibel Bravo, Ahmet Salduz, Kristen L. Shogren, Madison N. Okuno, James L. Herrick, Scott H. Okuno, Mario Galindo, Andre J. van Wijnen, Michael J. Yaszemski, Avudaiappan Maran. Decreased local and systemic levels of sFRP3 protein in osteosarcoma patients. Gene 2018; 674: 1 doi: 10.1016/j.gene.2018.06.059
|
64 |
Qihua Yang, Tao Huang, Guoliang Ye, Bojun Wang, Xinjun Zhang. Methylation of SFRP2 gene as a promising noninvasive biomarker using feces in colorectal cancer diagnosis: a systematic meta-analysis. Scientific Reports 2016; 6(1) doi: 10.1038/srep33339
|
65 |
Humberto J. Ferreira, Manel Esteller. CpG Islands. Methods in Molecular Biology 2018; 1766: 49 doi: 10.1007/978-1-4939-7768-0_4
|
66 |
Sonia Abou Najem, Ghada Khawaja, Mohammad Hassan Hodroj, Sandra Rizk. Synergistic Effect of Epigenetic Inhibitors Decitabine and Suberoylanilide Hydroxamic Acid on Colorectal Cancer In vitro. Current Molecular Pharmacology 2019; 12(4): 281 doi: 10.2174/1874467212666190313154531
|
67 |
Xinyan Liu, Jinming Fu, Haoran Bi, Anqi Ge, Tingting Xia, Yupeng Liu, Hongru Sun, Dapeng Li, Yashuang Zhao. DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6436-0
|
68 |
Lokesh Kumari Kadian, Ritu Yadav, Smiti Nanda, Gulshan Gulshan, Shivkant Sharma, Chetna Yadav. High-risk HPV infection modulates the promoter hypermethylation of APC, SFRP1, and PTEN in cervical cancer patients of North India. Molecular Biology Reports 2020; 47(12): 9725 doi: 10.1007/s11033-020-05960-z
|
69 |
Takashi Murakami, Hiroyuki Mitomi, Tsuyoshi Saito, Michiko Takahashi, Naoto Sakamoto, Naoshi Fukui, Takashi Yao, Sumio Watanabe. Distinct WNT/β-catenin signaling activation in the serrated neoplasia pathway and the adenoma-carcinoma sequence of the colorectum. Modern Pathology 2015; 28(1): 146 doi: 10.1038/modpathol.2014.41
|
70 |
Fiona C. Malcomson, Naomi D. Willis, Iain McCallum, Long Xie, Seamus Kelly, David Michael Bradburn, Nigel J. Belshaw, Ian T. Johnson, John C. Mathers. Adherence to the World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations and WNT-pathway-related markers of bowel cancer risk. British Journal of Nutrition 2019; 122(5): 509 doi: 10.1017/S0007114518002520
|
71 |
Nader Mansour Samaei, Yaghoub Yazdani, Reza Alizadeh-Navaei, Hossein Azadeh, Touraj Farazmandfar. Promoter methylation analysis of WNT/β-catenin pathway regulators and its association with expression of DNMT1 enzyme in colorectal cancer. Journal of Biomedical Science 2014; 21(1) doi: 10.1186/s12929-014-0073-3
|
72 |
James B Rawson, Bharati Bapat. Epigenetic biomarkers in colorectal cancer diagnostics. Expert Review of Molecular Diagnostics 2012; 12(5): 499 doi: 10.1586/erm.12.39
|
73 |
Su Jin Song, Sena Choi, Taesun Park, Ravirajsinh Jadeja. Decaffeinated Green Coffee Bean Extract Attenuates Diet‐Induced Obesity and Insulin Resistance in Mice. Evidence-Based Complementary and Alternative Medicine 2014; 2014(1) doi: 10.1155/2014/718379
|
74 |
Sebastian Pohl, Ross Scott, Frank Arfuso, Vanathi Perumal, Arun Dharmarajan. Secreted frizzled-related protein 4 and its implications in cancer and apoptosis. Tumor Biology 2015; 36(1): 143 doi: 10.1007/s13277-014-2956-z
|
75 |
Hisayuki Yao, Eishi Ashihara, Taira Maekawa. Targeting the Wnt/β-catenin signaling pathway in human cancers. Expert Opinion on Therapeutic Targets 2011; 15(7): 873 doi: 10.1517/14728222.2011.577418
|
76 |
Ana-Luisa Silva, Sarah N Dawson, Mark J Arends, Kiran Guttula, Nigel Hall, Ewen A Cameron, Tim H-M Huang, James D Brenton, Simon Tavaré, Mariann Bienz, Ashraf EK Ibrahim. Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-891
|
77 |
Zhengdong Yang, Xinyang Wang, Huiying Zhou, Minghan Jiang, Jinghui Wang, Bowen Sui. Molecular Complexity of Colorectal Cancer: Pathways, Biomarkers, and Therapeutic Strategies. Cancer Management and Research 2024; : 1389 doi: 10.2147/CMAR.S481656
|
78 |
Yukun Zhang, Hong Chen. Genistein attenuates WNT signaling by up-regulating sFRP2 in a human colon cancer cell line. Experimental Biology and Medicine 2011; 236(6): 714 doi: 10.1258/ebm.2011.010347
|
79 |
Youtu Wu, Jiwei Bai, Zhenye Li, Fei Wang, Lei Cao, Chunhui Liu, Shengyuan Yu, Guoqiang Yu, Yazhuo Zhang. Low expression of secreted frizzled-related protein 4 in aggressive pituitary adenoma. Pituitary 2015; 18(3): 335 doi: 10.1007/s11102-014-0579-4
|
80 |
Yang Xie, Feng Wang, Jun Yu, Jing Zhang, Yuting Liu, Mengying Li, Jian Qi. Silencing of MBD2 and EZH2 inhibits the proliferation of colorectal carcinoma cells by rescuing the expression of SFRP. Oncology Reports 2021; 46(6) doi: 10.3892/or.2021.8201
|
81 |
Laura Novellasdemunt, Pedro Antas, Vivian S. W. Li. Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms. American Journal of Physiology-Cell Physiology 2015; 309(8): C511 doi: 10.1152/ajpcell.00117.2015
|
82 |
Gernot Kriegshäuser, Dietmar Enko, Matthias Zitt, Michael Oberwalder, Christian Oberkanins, Dietmar Öfner, Robert Zeillinger, Hannes Maximilian Müller. Comparison of a Prototype Reverse Hybridization Assay and MethyLight for Detection of SFRP2 Promotor Methylation in Fecal DNA. The International Journal of Biological Markers 2017; 32(4): 467 doi: 10.5301/ijbm.5000289
|
83 |
Dalma Müller, Balázs Győrffy. DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(3): 188722 doi: 10.1016/j.bbcan.2022.188722
|
84 |
Jyothi S. Prabhu, Aruna Korlimarla, Arindam Banerjee, Shivangi Wani, K Payal, Rashmita Sahoo. Gene-Specific Methylation: Potential Markers for Colorectal Cancer. The International Journal of Biological Markers 2009; 24(1): 57 doi: 10.1177/172460080902400109
|
85 |
Jun Yu, Yang Xie, Mengying Li, Fenfang Zhou, Zhenyang Zhong, Yuting Liu, Feng Wang, Jian Qi. Association between SFRP promoter hypermethylation and different types of cancer: A systematic review and meta‑analysis. Oncology Letters 2019; doi: 10.3892/ol.2019.10709
|
86 |
Árpád V. Patai, Gábor Valcz, Péter Hollósi, Alexandra Kalmár, Bálint Péterfia, Árpád Patai, Barnabás Wichmann, Sándor Spisák, Barbara Kinga Barták, Katalin Leiszter, Kinga Tóth, Ferenc Sipos, Ilona Kovalszky, Zoltán Péter, Pál Miheller, Zsolt Tulassay, Béla Molnár, Ken Mills. Comprehensive DNA Methylation Analysis Reveals a Common Ten-Gene Methylation Signature in Colorectal Adenomas and Carcinomas. PLOS ONE 2015; 10(8): e0133836 doi: 10.1371/journal.pone.0133836
|
87 |
Rongbin Liu, Xuan Su, Yakang Long, Dalei Zhou, Xiao Zhang, Zulu Ye, Jiangjun Ma, Tao Tang, Fang Wang, Caiyun He. A systematic review and quantitative assessment of methylation biomarkers in fecal DNA and colorectal cancer and its precursor, colorectal adenoma. Mutation Research/Reviews in Mutation Research 2019; 779: 45 doi: 10.1016/j.mrrev.2019.01.003
|
88 |
Dong Tang, Daorong Wang, Hongbo Li. Combination analysis of hypermethylated SFRP1 and SFRP2 gene in fecal as a novel epigenetic biomarker panel for colorectal cancer screening. Journal of Nanjing Medical University 2008; 22(2): 96 doi: 10.1016/S1007-4376(08)60020-9
|